Life Sciences Nucleai Closes $33 Million Series B Financing to Advance Spatial Biology Platform for Drug Research,… AIT News Desk Apr 4, 2022 Led by Section 32 and Sanofi Ventures, funding will enable Nucleai to expand its commercial footprint in biopharma and further develop its…
Life Sciences MinervaX Raises Upsized Eur 47.4 Million (USD 57M) Series B to Advance Its Novel Group B… AIT News Desk Dec 16, 2020 On the back of highly promising Phase Ib data, MinervaX has raised financing from leading investors to accelerate development of its novel vaccine…